MX2024014602A - Metodo para producir particulas de virus adenoasociados (aav) recombinantes - Google Patents
Metodo para producir particulas de virus adenoasociados (aav) recombinantesInfo
- Publication number
- MX2024014602A MX2024014602A MX2024014602A MX2024014602A MX2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A
- Authority
- MX
- Mexico
- Prior art keywords
- recombinant aav
- aav particle
- cell solution
- production cell
- producing recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere a un método para producir una partícula de AAV recombinante que comprende las etapas de propagar una célula de mamífero mediante el uso de perfusión hasta que se obtiene al menos una primera densidad celular predeterminada; diluir una alícuota de las células propagadas mediante la adición de medio de cultivo fresco para obtener una solución de células de producción que tiene una segunda densidad celular predeterminada; cultivar la solución de células de producción durante 1 a 36 horas; transfectar las células directamente en la solución de células de producción cultivada con uno o más ácidos nucleicos que codifican la partícula de AAV recombinante; y cultivar la solución de células de producción transfectada durante 24 a 144 horas, con lo cual se produce una partícula de AAV recombinante.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22177118 | 2022-06-03 | ||
| PCT/EP2023/064647 WO2023232922A1 (en) | 2022-06-03 | 2023-06-01 | Method for producing recombinant aav particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024014602A true MX2024014602A (es) | 2025-01-09 |
Family
ID=82218399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024014602A MX2024014602A (es) | 2022-06-03 | 2024-11-26 | Metodo para producir particulas de virus adenoasociados (aav) recombinantes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250313854A1 (es) |
| EP (1) | EP4532737A1 (es) |
| JP (1) | JP2025519228A (es) |
| KR (1) | KR20250020470A (es) |
| CN (1) | CN119301260A (es) |
| AR (1) | AR129500A1 (es) |
| AU (1) | AU2023278422A1 (es) |
| CA (1) | CA3258165A1 (es) |
| MX (1) | MX2024014602A (es) |
| TW (1) | TW202405182A (es) |
| WO (1) | WO2023232922A1 (es) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US6093699A (en) | 1987-07-09 | 2000-07-25 | The University Of Manitoba | Method for gene therapy involving suppression of an immune response |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| ATE159548T1 (de) | 1990-11-13 | 1997-11-15 | Immunex Corp | Bifunktionelle wählbare fusionsgene |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| WO1994017810A1 (en) | 1993-02-12 | 1994-08-18 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| WO1994023744A1 (en) | 1993-04-16 | 1994-10-27 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| US6100242A (en) | 1995-02-28 | 2000-08-08 | The Regents Of The University Of California | Gene therapies for enhancing cardiac function |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| US6004797A (en) | 1995-11-09 | 1999-12-21 | Avigen, Inc. | Adenovirus helper-free recombinant AAV Virion production |
| US6228646B1 (en) | 1996-03-07 | 2001-05-08 | The Regents Of The University Of California | Helper-free, totally defective adenovirus for gene therapy |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| DE19955558C2 (de) | 1999-11-18 | 2003-03-20 | Stefan Kochanek | Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren |
| AU2001257611A1 (en) | 2000-04-28 | 2001-11-12 | Avigen, Inc. | Polynucleotides for use in recombinant adeno-associated virus virion production |
| US6593123B1 (en) | 2000-08-07 | 2003-07-15 | Avigen, Inc. | Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| JP4559429B2 (ja) | 2003-05-21 | 2010-10-06 | ジェンザイム・コーポレーション | 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法 |
| DE102005054628A1 (de) | 2005-11-16 | 2007-05-24 | Cevec Pharmaceuticals Gmbh | Verfahren zur Herstellung von permanenten humanen Zelllinien |
| EP2529020B1 (en) | 2010-01-28 | 2018-04-25 | The Children's Hospital of Philadelphia | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| EP3795581A3 (en) | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| JP6342886B2 (ja) | 2012-04-18 | 2018-06-13 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia | Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法 |
| NZ716102A (en) | 2013-07-22 | 2021-12-24 | The Children’S Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| EP3384015A4 (en) | 2015-12-01 | 2019-05-29 | Spark Therapeutics, Inc. | SCALABLE PROCESS FOR THE PREPARATION OF A RECOMBINANT ADENO ASSOCIATED VIRAL VECTOR IN A SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR THE CLINICAL APPLICATION |
| WO2018226887A1 (en) | 2017-06-07 | 2018-12-13 | Spark Therapeutics, Inc. | ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION |
| EP3658250A4 (en) | 2017-06-30 | 2021-10-27 | Spark Therapeutics, Inc. | AAV VECTOR COLUMN CLEANING PROCEDURE |
| WO2020086408A1 (en) * | 2018-10-26 | 2020-04-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | A high-yield perfusion-based transient gene expression bioprocess |
| US20220098556A1 (en) | 2019-01-25 | 2022-03-31 | Biogen Ma Inc. | Seed culture process for aav production |
| EP4006141A1 (en) * | 2020-11-25 | 2022-06-01 | CEVEC Pharmaceuticals GmbH | Method for the production of aav |
-
2023
- 2023-06-01 JP JP2024570988A patent/JP2025519228A/ja active Pending
- 2023-06-01 AR ARP230101390A patent/AR129500A1/es unknown
- 2023-06-01 EP EP23729772.6A patent/EP4532737A1/en active Pending
- 2023-06-01 AU AU2023278422A patent/AU2023278422A1/en active Pending
- 2023-06-01 CN CN202380043060.9A patent/CN119301260A/zh active Pending
- 2023-06-01 CA CA3258165A patent/CA3258165A1/en active Pending
- 2023-06-01 KR KR1020247041929A patent/KR20250020470A/ko active Pending
- 2023-06-01 WO PCT/EP2023/064647 patent/WO2023232922A1/en not_active Ceased
- 2023-06-02 TW TW112120675A patent/TW202405182A/zh unknown
-
2024
- 2024-11-26 MX MX2024014602A patent/MX2024014602A/es unknown
- 2024-12-02 US US18/965,956 patent/US20250313854A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023278422A1 (en) | 2024-11-14 |
| JP2025519228A (ja) | 2025-06-24 |
| EP4532737A1 (en) | 2025-04-09 |
| AR129500A1 (es) | 2024-09-04 |
| US20250313854A1 (en) | 2025-10-09 |
| WO2023232922A1 (en) | 2023-12-07 |
| KR20250020470A (ko) | 2025-02-11 |
| TW202405182A (zh) | 2024-02-01 |
| CN119301260A (zh) | 2025-01-10 |
| CA3258165A1 (en) | 2023-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020013633A (es) | Metodos para producir proteinas recombinantes. | |
| Paran et al. | The continued requirement for inducer for the development of macrophage and granulocyte colonies | |
| RU2009143635A (ru) | Улучшение титра полипептида фактора viii в клеточных культурах | |
| RU2008152449A (ru) | Получение гликопротеинов | |
| ATE359358T1 (de) | Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden | |
| ATE420198T1 (de) | Methylotrophe hefe,die eine zuckerkette eines säugers herstellt | |
| CO6491119A2 (es) | Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo | |
| BR0311413A (pt) | Desenvolvimento e transdiferenciação de células acinares humanas | |
| RU98107565A (ru) | Получение рекомбинантного фактора viii в среде, не содержащей белка | |
| PT1002080E (pt) | Proteinas fluorescentes como reporter especifico de tipo de celulas | |
| AR052028A1 (es) | Medio de cultivo de celula libre de suero para las celulas de los mamiferos | |
| Polisetti et al. | Efficient isolation and functional characterization of niche cells from human corneal limbus | |
| Al-Shaibani | Three-dimensional cell culture (3DCC) improves secretion of signaling molecules of mesenchymal stem cells (MSCs) | |
| Egger et al. | From 3D to 3D: isolation of mesenchymal stem/stromal cells into a three-dimensional human platelet lysate matrix | |
| JPWO2022019306A5 (es) | ||
| CN115951057B (zh) | 一种迁移体标记物 | |
| RU2014115731A (ru) | Добавление железа для улучшения культивирования клеток | |
| Bertoncello et al. | Isolation and clonal assay of adult lung epithelial stem/progenitor cells | |
| JP2022119210A5 (es) | ||
| Matsuura et al. | Adequate taylor couette flow-mediated shear stress is useful for dissociating human iPS cell-derived cell aggregates | |
| AR129500A1 (es) | Método para producir partículas de aav recombinante | |
| AR129895A1 (es) | Método para producir partículas de aav recombinantes | |
| CN104911104B (zh) | 细胞及器官体外3‑d培养装置及人工器官培育的方法 | |
| Yu et al. | Clonal isolation of human pluripotent stem cells on nanofibrous substrates reveals an advanced subclone for cardiomyocyte differentiation | |
| CN107142236B (zh) | 一种将胚胎肝内胆管上皮细胞诱导分化为含成熟胆管上皮细胞和胆管结构的细胞模型的方法 |